comparemela.com

Latest Breaking News On - Nd pdsb us70465t1079 - Page 1 : comparemela.com

PDS Biotechnology Post-ASCO Conference Call Tomorrow, June 6, at 8 a m ET

FLORHAM PARK, N.J., June 05, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | June 5, 2023

United statesDeanne randolphDave schemeliaBiotechnology corporationBiotechnology corporation nasdaqAmerican society for clinical oncologyGlobenewswire incClinical oncologyCall informationPds biotechnology corporation stock exchangePress releaseNd pdsb us70465t1079

PDS Biotech Supports Oral, Head & Neck Cancer Awareness Month During April and Oral, Head & Neck Cancer Awareness Week from April 16-22, 2023

FLORHAM PARK, N.J., April 03, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | April 3, 2023

United statesDeanne randolphAmanda hollingerDave schemeliaKenji hisamatsuFrank beduGlobenewswire incNational cancer instituteBiotechnology corporation nasdaqBiotechnology corporation the companyHead neck cancer allianceDrug administrationNeck cancer allianceAmerican society for clinical oncologyMerck co incUnited states securities exchange

PDS Biotech to Participate in Cantor s Future of Oncology Virtual Symposium

FLORHAM PARK, N.J., March 29, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | March 29, 2023

Deanne randolphDave schemeliaFrank beduTiberend strategic advisors incBiotechnology corporation nasdaqGlobenewswire incBiotechnology corporationChief executive officerOncology virtual symposiumStrategic advisorsPds biotechnology corporation stock exchangePress releaseNd pdsb us70465t1079

vimarsana © 2020. All Rights Reserved.